SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Levin Arthur A – ‘4’ for 4/19/24 re: Avidity Biosciences, Inc.

On:  Monday, 4/22/24, at 5:28pm ET   ·   For:  4/19/24   ·   As:  Director   ·   Accession #:  1599901-24-53   ·   File #:  1-39321

Previous ‘4’:  ‘4’ on / for 4/3/24   ·   Latest ‘4’:  This Filing

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/22/24  Levin Arthur A                    4          Director    1:8K   Avidity Biosciences, Inc.         Avidity Biosciences, Inc

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      9K 
                Securities by an Insider --                                      
                wk-form4_1713821325.xml/5.8


        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
SEC Info℠ rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider — wk-form4_1713821325.xml/5.8
 

The SEC has not released XSLT Stylesheets needed to render this File’s XML Data as a Form.

This is our “Plain Text” rendering:
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0508
Document Type:  4
Period of Report:  4/19/24
Not Subject to Section 16:  0
Issuer:
Issuer CIK:  1599901
Issuer Name:  Avidity Biosciences, Inc.
Issuer Trading Symbol:  RNA
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1181556
Owner Name:  LEVIN ARTHUR A
Reporting Owner Address:
Owner Street 1:  C/O AVIDITY BIOSCIENCES, INC.
Owner Street 2:  10578 SCIENCE CENTER DRIVE, SUITE 125
Owner City:  SAN DIEGO
Owner State:  CA
Owner ZIP Code:  92121
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  No
Is Ten Percent Owner?  No
Is Other?  No
Aff 10b5 One:  1
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  4/19/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  M
Equity Swap Involved?  No
Footnote ID:  F1
Transaction Amounts:
Transaction Shares:
Value:  5,000
Transaction Price Per Share:
Value:  1.24
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  19,830
Footnote ID:  F2
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  4/19/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  S
Equity Swap Involved?  No
Footnote ID:  F1
Transaction Amounts:
Transaction Shares:
Value:  5,000
Transaction Price Per Share:
Value:  22.8246
Footnote ID:  F3
Transaction Acquired-Disposed Code:
Value:  D
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  14,830
Footnote ID:  F2
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Non-Derivative Holding:
Security Title:
Value:  Common Stock
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  253,872
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  By family trust
Derivative Table:
Derivative Transaction:
Security Title:
Value:  Stock Option (Right to Buy)
Conversion or Exercise Price:
Value:  1.24
Transaction Date:
Value:  4/19/24
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  M
Equity Swap Involved?  No
Footnote ID:  F1
Transaction Amounts:
Transaction Shares:
Value:  5,000
Transaction Price Per Share:
Value:  0
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F4
Expiration Date:
Value:  2/18/30
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  5,000
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  33,323
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Footnotes:
Footnote - F1:  The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Footnote - F2:  Includes the following securities previously acquired by the Reporting Person: (i) 13,500 RSUs under the Issuer's 2020 Incentive Award Plan and (ii) 1,330 shares of common stock under the Issuer's 2020 Employee Stock Purchase Plan.
Footnote - F3:  This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.25 to $23.56. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote - F4:  All unexercised shares subject to the option are fully vested and exercisable as of the date hereof.
Remarks:
Owner Signature:
Signature Name:  /s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact
Signature Date:  4/22/24


↑Top
Filing Submission 0001599901-24-000053   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., May 14, 10:03:04.2pm ET